Search - tctmd.com

Displaying 101 - 120 of 140

Sort: Relevancy | Date

Presentation TCT 2014

TCT 610: Prospective, Multicenter Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and 2-Year Clinical Results

Presenter: Alexandre Abizaid, Dean J. Kereiakes, Vasim Farooq

September 16, 2014

Presentation TCT 2014

BRS with Clinical Data I DESolve: Differentiating Features and Clinical Update

Presenter: Alexandre Abizaid, Dean J. Kereiakes, Vasim Farooq, Stefan Verheye

September 16, 2014

Presentation TCT 2014

Absorb III/IV: Testing Noninferiority and Superiority

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Dean J. Kereiakes

September 16, 2014

Presentation TCT 2014

Differences Between Polymeric and Metallic Bioresorbable Scaffolds

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Ron Waksman

September 16, 2014

Presentation TCT 2014

Scaffolds vs Stents: 5-Year Insights from Longitudinal Imaging Studies

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Yoshinobu Onuma

September 16, 2014

Presentation TCT 2014

Scaffolds vs Stents: Biomechanics and Vascular Responses

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Juan F. Granada

September 16, 2014

Presentation TCT 2014

The Inexorable Accumulation of Late Events After Metallic BMS and DES: Mechanisms and Clinical Data

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Stephen G. Ellis

September 16, 2014

News Industry News

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

September 15, 2014

Presentation TCT 2014

Why Optimal Lesion Preparation for BRS Is Critical and How to Achieve It

Presenter: Antonio Colombo, Nicolas M. van Mieghem, Dean J. Kereiakes

September 14, 2014

Presentation TCT 2014

How Did I Treat This Patient?

Presenter: Eric A. Cohen, Dean J. Kereiakes, Samer Mansour

September 14, 2014

Presentation TCT 2014

How Would I Treat This Patient?

Presenter: Eric A. Cohen, Dean J. Kereiakes, Stuart Watkins

September 14, 2014

Presentation TCT 2014

Case #3. Multivessel Disease in a Stable CAD Patient

Presenter: Eric A. Cohen, Dean J. Kereiakes, Samer Mansour

September 14, 2014

Presentation TCT 2014

How Did I Treat This Patient?

Presenter: Dean J. Kereiakes, Margaret B. McEntegart, Stuart Watkins, Colin Berry

September 14, 2014

Presentation TCT 2014

Case #2: Multivessel Disease in an NSTEMI Patient

Presenter: Dean J. Kereiakes, Margaret B. McEntegart, Stuart Watkins, Colin Berry

September 14, 2014

Presentation TCT 2014

How Did I Treat This Patient?

Presenter: Dean J. Kereiakes, Margaret B. McEntegart, Stuart Watkins, Keith G. Oldroyd

September 14, 2014

Presentation BRS 2014

Bioresorbable Scaffolds and Angina post-PCI: A New Paradigm Shifting Hypothesis

Presenter: Dean J. Kereiakes

July 25, 2014

News Conference News ACC 2014

ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates

Yael L. Maxwell

March 31, 2014

News Industry News

Boston Scientific Announces Schedule for Presentations at American College of Cardiology 2014

March 27, 2014

News Industry News

Abbott Completes Enrollment of Absorb™ Randomized Clinical Trials in the United States, Japan and China

March 10, 2014

News Conference News TCT 2013

OPTIMIZE: 3-Month DAPT Safe with ZES

October 31, 2013

Advertisement

TCT 610: Prospective, Multicenter Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and 2-Year Clinical Results

BRS with Clinical Data I DESolve: Differentiating Features and Clinical Update

Absorb III/IV: Testing Noninferiority and Superiority

Differences Between Polymeric and Metallic Bioresorbable Scaffolds

Scaffolds vs Stents: 5-Year Insights from Longitudinal Imaging Studies

Scaffolds vs Stents: Biomechanics and Vascular Responses

The Inexorable Accumulation of Late Events After Metallic BMS and DES: Mechanisms and Clinical Data

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

Why Optimal Lesion Preparation for BRS Is Critical and How to Achieve It

How Did I Treat This Patient?

How Would I Treat This Patient?

Case #3. Multivessel Disease in a Stable CAD Patient

How Did I Treat This Patient?

Case #2: Multivessel Disease in an NSTEMI Patient

How Did I Treat This Patient?

Bioresorbable Scaffolds and Angina post-PCI: A New Paradigm Shifting Hypothesis

ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates

Boston Scientific Announces Schedule for Presentations at American College of Cardiology 2014

Abbott Completes Enrollment of Absorb™ Randomized Clinical Trials in the United States, Japan and China

OPTIMIZE: 3-Month DAPT Safe with ZES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content